Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Loiasis is a rarely imported infectious disease that is often difficult to diagnose and treat. Here we describe clinical features and treatment outcomes of 11 patients with imported loiasis seen at a German reference center between 2013 and 2023. Clinical presentations varied by patient origin, with eye-worm migration and ophthalmological symptoms being more common among patients from endemic areas and Calabar swelling, subcutaneous swelling, and pruritus more prevalent among returning travelers from nonendemic regions. Eosinophil counts were higher in returning travelers. Diethylcarbamazine was most commonly used for treatment either as monotherapy in combination with ivermectin or with albendazole and ivermectin, respectively. In one patient, long-term follow-up indicated treatment failure after the first course of treatment. Another traveler was prescribed chemoprophylaxis with diethylcarbamazine after experiencing repeated infections due to long-term residence in a high-risk region in Cameroon.

Citation

Tamara Nordmann, Julia Ruge, Dennis Tappe, Michael Ramharter. Imported Loiasis at a Clinical Reference Center in Germany: A Retrospective Case Series. The American journal of tropical medicine and hygiene. 2024 Sep 04;111(3):521-525

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38981492

View Full Text